RIDGELINE

Pharmaceutical products, namely, preparations for treatment of medical conditions in the fields of cardiology, endocrinology, hepatology, hematology, gastroenterology, immunology, infectious disease, virology and bacteriology, neuroscience, oncology, ophthalmology, pulmonology, urology, dermatology, gynecology and obstetrics, and pain management; biotechnological preparations for use in the treatment of medical conditions in the fields of cardiology, endocrinology, hepatology, hematology, gastroenterology, immunology, infectious disease, virology and bacteriology, neuroscience, oncology, ophthalmology, pulmonology, urology, dermatology, gynecology and obstetrics, and pain management